维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Topoi E"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus 显示文摘	Nissen S E Wolski K Topoi E J	2005	J Am Med Assoc2005，294，20：	1
2	Tissue factor, the emerging link between inflammation, thrombosis and vascular remodeling 显示文摘	Penn M Topoi E	2001	Cir Res2001，89，1：	1
3	Relatioship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk显示文摘	Bhattacharyya T Nicholls S J Topoi E J	2008	JAMA2008，299，11：	1
4	The restenosis paradigm revisited: an alternative proposal for cellular mechanisms显示文摘	Schwartz R S HOlmes D R Jr Topoi E J	1992	J Am Coll Cardiol1992，20，5：	1
5	Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions显示文摘	Abdelmeguid AE Topoi E J Whitlow PL	1996	Circulation1996，94，7：	1
6	Effect of lipid - lowering ther- apy on early mortality after acute coronary syndromes: an observational study 显示文摘	Aronow HD Topoi E J Roe MT	2001	Lancet2001，357，9262：	1
7	Early Reinfarction After Fibrinolysis:Experience From the Global Utilization of Streptoki- nase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries ( GUSTO I ) and Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO III) Trials显示文摘	Hudson MP Granger CB Topoi E J	2001	Circu- lation2001，104，11：	1
8	Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) Ⅲ Trial 显示文摘	Topoi E J Ohman E M Armstrong P W	2000	Circulation2000，102，：	1
9	Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41021 patients显示文摘	Lee K L Woodier L H Topoi E J	1995	Circulation1995，91，1：	1
10	Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, ereatine kinase-MB, and clinical variables显示文摘	Christenson R Ohman E Topoi E	1997	Circulation1997，96，：	1
11	Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention显示文摘	Motwani JG Topoi E J	1998	Circulation1998，97，9：	1
12	Recognition of the importance of emboli-zation in atherosclerotie vascular disease 显示文摘	TOPOI E J YADAV J S	2000	Circulation2000，101，5：	1
13	Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins显示文摘	Casserty I Topoi E	2004	Lancet2004，363，9415：	1
14	Occurrence and clinical significance of pseudothrombocytopenia during abcix- imab therapy 显示文摘	Sane DC Damaraju LV Topoi E J	2000	J Am Coil Cardiol2000，36，1：	1
15	Relationship between antecedent angina pectofis and short-term prognosis after thrombolytic therapy for acute myocardial infarction, thrombolysis and angioplasty in myocardial infarction(TAMI) study group显示文摘	Muller DM Topoi E J Califf RM	1990	Am Heart J1990，119，：	1
16	Recognition of the importance of emboli-zation in atherosclerotic vascular disease显示文摘	TOPOI E J YADAV J S	2000	Circulation2000，101，5：	1
17	Recognition of the importance if embolization in atherosclerotic vascular disease 显示文摘	Topoi E J Yadav J S	2000	Circulation2000，101，5：	1
18	Frontiers in interventional cardiology显示文摘	Topoi E J Serruys PW	1998	Circulation1998，98，17：	1
19	Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction 显示文摘	Wessel J Topoi E J Ji M	2004	Am Heart J2004，147，5：	1
20	Pharmacological approaches for the prevention of restenos after percutaneous coronary intervention 显示文摘	Lefkovits J Topoi E J	1997	Prog Cardiovase1997，40，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示